Apollon
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $3.6M
Investors
- 9
About Apollon
Based in Seoul, South Korea, and founded in 2021, Apollon Inc. operates as a provider of needleless glucose monitoring devices. As of 2023, the company is headed by its CEO Aram Hong. In September 2026, Apollon Inc. The company develops and manufactures needleless continuous glucose monitoring (CGM) equipment using in vivo Raman glucose peaks that measure blood sugar levels in patients. The firm device is of smartwatch size without any needle and sensor applicator.
Who invested in Apollon
9 investors across 3 rounds
See all investors in Apollon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Apollon
Who invested in Apollon?
Apollon has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apollon raised?
Apollon has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Apollon last raise money?
Apollon's most recent round on record is a Series A, in Sep 2026.
What does Apollon do?
Based in Seoul, South Korea, and founded in 2021, Apollon Inc.
Where is Apollon headquartered?
Apollon is headquartered in Seoul, South Korea.
Which VCs invest in companies like Apollon?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Apollon's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Apollon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.